Current Research

Research for fallopian tube cancer is ongoing. The following advances may still be under investigation in clinical trials and may not be approved or available at this time. Always discuss all diagnostic and treatment options with your doctor.

Because fallopian tube cancer is so rare, fallopian tube cancer-specific clinical trials may be hard to find. However, because it is similar to ovarian cancer, researchers are trying to determine if it can be treated similarly. Therefore, many clinical trials may include patients with either ovarian or fallopian tube cancer.

In addition, genetic research has shown that mutations to the BRCA1 gene may increase the risk of developing fallopian tube cancer. Further research in this area may help clarify the risk and also result in better patient counseling for women who carry a mutation to this gene.